• news.cision.com/
  • Pandox/
  • Invitation to presentation of Pandox’s interim report January–September 2024

Invitation to presentation of Pandox’s interim report January–September 2024

Report this content

Pandox AB (publ) publishes the interim report for the period January–September 2024 on 24 October 2024, at 07:00 CEST, followed by a webcasted telephone conference at 08:30 CEST.

 

Afterwards, a proprietary presentation on the international hotel market, separate from Pandox’s earnings presentation, will be held by Thomas Emanuel, Senior Director at STR International.

Teleconference

If you wish to participate via teleconference, please register via the following link: https://conference.financialhearings.com/teleconference/?id=50048984. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference. 

Webcast

If you wish to participate via webcast, please use the following link: https://tv.streamfabriken.com/pandox-q3-report-2024. Via the webcast you can ask written questions.

A recorded version of the webcast will be available at www.pandox.se.

FOR MORE INFORMATION, PLEASE CONTACT:

Anders Berg, SVP Head of Communications and IR, +46 (0) 760 95 19 40
Erik Ax Rabaeus, Director, IR & Communications +46 (0) 70 713 77 06

The information was submitted for publication, through the agency of the contact persons set out above, at 10:00 CEST on 10 October 2024.

 

 

 

 

 

About Pandox
Pandox owns, develops, and leases hotel properties to skilled hotel operators under long-term, turnover-based leases with minimum guaranteed levels. Since our inception in 1995, we have grown into one of the largest hotel property owners in Europe. Our portfolio consists of 161 hotel properties with approximately 35,600 rooms across 11 countries in Northern Europe. The portfolio's market value is approximately SEK 70bn. The head quarter is in Stockholm, and we are listed on Nasdaq Stockholm.  www.pandox.se

Tags:

Subscribe

Documents & Links